Effects of Sage on Memory and Mental Performance in Alzheimer's Disease Patients

Phase 1

Completed

• Conditions: Alzheimer Disease
• Interventions: Drug: Salvia officinalis (sage)

• Registration Number: NCT00110552
• Lead Sponsor: Oregon Health and Science University

Brief Summary

The purpose of this study is to determine the effectiveness of the herb sage in improving the mental function of individuals with Alzheimer's disease.

Study hypothesis: The administration of sage will improve cognitive function in patients with mild Alzheimer's disease.

Detailed Description

The herb sage has been shown to enhance memory and mental function in healthy, young adults. However, studies assessing the herb's effectiveness in older adults with symptoms of Alzheimer's disease are limited. This study will determine the effect of sage extract on the cognitive function of patients with mild Alzheimer's disease.

This study will last 6 weeks and will comprise 4 study visits, approximately 10 days apart. Participants will be randomly assigned to receive either sage pills or no treatment during each 10-day period. The treatment assignments will be switched in 10-day intervals, so that during the course of the study, each participant will undergo two periods of sage treatment and two periods without treatment. At each study visit, participants will undergo cognitive testing, including tests to determine attention, memory, and visual cognition. Participants will also undergo an electroencephalogram (EEG) and an electrocardiogram (ECG) at each visit.

Study Timeline

• Study First Submitted: 2005-05-10
• Study First Submitted QC: 2005-05-10
• Study First Posted: 2005-05-11
• Study Start: 2005-07
• Primary Completion: 2012-12
• Status Verified: 2014-10
• Study Completion: 2014-10
• Last Update Submitted: 2014-10-27
• Last Update Posted: 2014-10-29

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 111

Inclusion Criteria

• Diagnosis of mild Alzheimer's disease
• Partner, friend, child, spouse, or relative willing to accompany participants to all study visits, provide informed consent, monitor participants' pill-taking, and communicate changes in participants' health during the study

Exclusion Criteria

• Significant medical illness other than Alzheimer's disease

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
1	Salvia officinalis (sage)	Sage capsules taken by mouth

Primary Outcome Measures

Name	Time	Method
Cognitive function	8 weeks

Secondary Outcome Measures

Name	Time	Method
Stress	8 weeks
cognitive electrophysiology	8 weeks

Trial Locations

Locations (1)

Oregon Health and Science University; 🇺🇸 Portland, Oregon, United States